Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TRY 8,151.62 million compared to TRY 10,639.34 million a year ago. Net income was TRY 454.58 million compared to TRY 639.95 million a year ago.
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
Equities
GENIL
TREGENL00024
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.9 TRY | -0.71% | -6.68% | +19.24% |
1st Jan change | Capi. | |
---|---|---|
+19.24% | 524M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- GENIL Stock
- News Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
- Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023